Ş. LAÇİN Et Al. , "Metastatic medullary thyroid cancer: a dramatic response to a systemic chemotherapy (temozolomide and capecitabine) regimen," ONCOTARGETS AND THERAPY , vol.8, pp.1039-1042, 2015
LAÇİN, Ş. Et Al. 2015. Metastatic medullary thyroid cancer: a dramatic response to a systemic chemotherapy (temozolomide and capecitabine) regimen. ONCOTARGETS AND THERAPY , vol.8 , 1039-1042.
LAÇİN, Ş., Esin, E., Karakas, Y., & YALÇIN, Ş., (2015). Metastatic medullary thyroid cancer: a dramatic response to a systemic chemotherapy (temozolomide and capecitabine) regimen. ONCOTARGETS AND THERAPY , vol.8, 1039-1042.
LAÇİN, ŞAHİN Et Al. "Metastatic medullary thyroid cancer: a dramatic response to a systemic chemotherapy (temozolomide and capecitabine) regimen," ONCOTARGETS AND THERAPY , vol.8, 1039-1042, 2015
LAÇİN, ŞAHİN Et Al. "Metastatic medullary thyroid cancer: a dramatic response to a systemic chemotherapy (temozolomide and capecitabine) regimen." ONCOTARGETS AND THERAPY , vol.8, pp.1039-1042, 2015
LAÇİN, Ş. Et Al. (2015) . "Metastatic medullary thyroid cancer: a dramatic response to a systemic chemotherapy (temozolomide and capecitabine) regimen." ONCOTARGETS AND THERAPY , vol.8, pp.1039-1042.
@article{article, author={ŞAHİN LAÇİN Et Al. }, title={Metastatic medullary thyroid cancer: a dramatic response to a systemic chemotherapy (temozolomide and capecitabine) regimen}, journal={ONCOTARGETS AND THERAPY}, year=2015, pages={1039-1042} }